Cellect Biotechnology Ltd. (Nasdaq: APOP) to Ring The Nasdaq Stock Market Opening Bell
24 2월 2017 - 12:00AM
What: Cellect Biotechnology Ltd.
(Nasdaq:APOP), a developer of stem cells isolation technology, will
visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Shai Yarkoni, CEO &
Co-Founder and Kasbian Nuriel Chirich – Chairman
of the Board and Co-Founder, will ring
the Opening Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Friday, February 24, 2017 – 9:15 a.m. to
9:30 a.m. ET
Cellect Biotechnology Media Contact:Eyal
Leibovitz - CFO+972-52-2552222eyal@cellectbio.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Opening
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Open, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market open of your choice.
About Cellect Biotechnology Ltd.Cellect
Biotechnology is traded on both the NASDAQ and Tel Aviv Stock
Exchange (NASDAQ:APOP) (NASDAQ:APOPW) (TASE:APOP). The Company has
developed a breakthrough technology for the isolation of stem cells
from any given tissue that aims to improve a variety of stem cells
applications. The Company’s technology is expected to provide
pharma companies, medical research centers and hospitals with the
tools to rapidly isolate stem cells in quantity and quality that
will allow stems cell related treatments and procedures. Cellect’s
technology is applicable to a wide variety of stem cells related
treatments in regenerative medicine and that current clinical
trials are aimed at the cancer treatment of bone marrow
transplantations.
About NasdaqNasdaq (Nasdaq:NDAQ) is a leading
provider of trading, clearing, exchange technology, listing,
information and public company services across six continents.
Through its diverse portfolio of solutions, Nasdaq enables clients
to plan, optimize and execute their business vision with
confidence, using proven technologies that provide transparency and
insight for navigating today's global capital markets. As the
creator of the world's first electronic stock market, its
technology powers more than 85 marketplaces in 50 countries, and 1
in 10 of the world's securities transactions. Nasdaq is home to
approximately 3,800 listed companies with a market value of $10.1
trillion and nearly 18,000 corporate clients. To learn more, visit:
business.nasdaq.com.
-NDAQA-
Cellect Biotechnology (NASDAQ:APOPW)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Cellect Biotechnology (NASDAQ:APOPW)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025
